1. Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer
    Dongxing Ji et al, 2017, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
  2. Cannabinoids for Neurological Conditions
    Baye G. Williamson et al, 2021, Cannabis Therapy in Veterinary Medicine CrossRef
  3. Shiga toxin-2 enhances heat-shock-induced apoptotic cell death in cultured and primary glial cells
    Naotoshi Sugimoto et al, 2014, Cell Biology and Toxicology CrossRef
  4. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
    Shuanglin Deng et al, 2014, Protein & Cell CrossRef
  5. The evolving role of the endocannabinoid system in gynaecological cancer
    Thangesweran Ayakannu et al, 2015, Human Reproduction Update CrossRef
  6. Cannabinoids as therapeutic agents in cancer: current status and future implications
    Bandana Chakravarti et al, 2014, Oncotarget CrossRef
  7. For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
    Rebecca J. Henry et al, 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry CrossRef
  8. Theobromine, the Primary Methylxanthine Found inTheobroma cacao, Prevents Malignant Glioblastoma Proliferation by Negatively Regulating Phosphodiesterase-4, Extracellular Signal-regulated Kinase, Akt/mammalian Target of Rapamycin Kinase, and Nuclear Factor-Kappa B
    Naotoshi Sugimoto et al, 2014, Nutrition and Cancer CrossRef
  9. Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
    Kathleen L. McCoy, 2016, Mediators of Inflammation CrossRef
  10. Corticosterone inhibits the expression of cannabinoid receptor‑1 and cannabinoid receptor agonist‑induced decrease in cell viability in glioblastoma cells
    Naotoshi Sugimoto et al, 2019, Oncology Letters CrossRef
  11. Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis
    John-Mark K. Fitzpatrick et al, 2017, Neuropharmacology CrossRef
  12. Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
    Yang Xun et al, 2021, Journal of Hematology & Oncology CrossRef
  13. Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction
    Austin R. Jackson et al, 2014, PLoS ONE CrossRef
  14. Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications
    Abdul Samad Basheer et al, 2021, Cancers CrossRef
  15. Effects of Peptidoglycan, Lipoteichoic Acid and Lipopolysaccharide on Inflammation, Proliferation and Milk Fat Synthesis in Bovine Mammary Epithelial Cells
    Yongjiang Wu et al, 2020, Toxins CrossRef
  16. HYPOXIA DOWNREGULATES CANNABINOID RECEPTORS, UPREGULATES COX-2, AND ATTENUATES CANNABINOID RECEPTOR AGONIST-INDUCED CELL DEATH IN GLIOBLASTOMA CELLS
    Naotoshi Sugimoto et al, 2018, Pathophysiology CrossRef
  17. Efficacy of cannabinoids against glioblastoma multiforme: A systematic review
    Ismini Kyriakou et al, 2021, Phytomedicine CrossRef
  18. PD-L1/PD-1 Axis in Glioblastoma Multiforme
    Jakub Litak et al, 2019, International Journal of Molecular Sciences CrossRef
  19. Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites
    Caroline Turcotte et al, 2015, Journal of Leukocyte Biology CrossRef